Biostem U.S. Corporation Announces National Expansion Plan to be Implemented by Founding CEO

CLEARWATER, FL--(Marketwired - April 08, 2013) - Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, today reported that it has reinstated its founder, John Satino as CEO, under whose leadership the Company will launch an aggressive campaign of national expansion and growth into even other fields of regenerative medicine.

Biostem Chief Executive Officer John Satino stated, "After several months of strategic planning, we have decided to realign with our original vision of providing exclusive use of The Biostem Method™ to doctors and clinics across the U.S. It is time to bring our focus back home! I am excited about the future growth Biostem and its affiliates will experience in the upcoming months and years and am proud of the impact we will have on improving the quality of life for patients."

About Biostem U.S., Corporation:

Biostem U.S., Corporation is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem is a technology licensing company with proprietary technology centered on providing hair re-growth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S., Corporation is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind.

For further information contact Biostem U.S., Corporation at 727-446-5000, send an email to info@biostem.us, or view the Biostem website at www.biostemus.com.